Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neural Transmission"
DOI: 10.1007/s00702-022-02485-6
Abstract: Risperidone is commonly used to treat different psychiatric disorders worldwide. Knowledge on dose–concentration relationships of risperidone treatment in children and adolescents with schizophrenia or other psychotic disorders is, however, scarce and no age-specific therapeutic ranges… read more here.
Keywords: drug; concentration; risperidone; adolescents schizophrenia ... See more keywords
Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Child and Adolescent Psychopharmacology"
DOI: 10.1089/cap.2021.0013
Abstract: Objectives: To evaluate the short-term efficacy and safety of blonanserin in adolescents with schizophrenia. Methods: This 6-week multicenter, double-blind, randomized, placebo-controlled study investigated fixed-dose blonanserin (8 or 16 mg/day) in patients 12–18 years of age diagnosed… read more here.
Keywords: safety; study; day; efficacy ... See more keywords